When it comes to treating serious cases of COVID-19, the antiviral drug Remdesivir helps. So do steroids, which can serve to reduce inflammation. And supplemental oxygen, as most Americans familiar with the basics of the coronavirus pandemic might guess, can ease shortness of breath.
The jury’s still out on convalescent plasma, however, despite plenty of hype and U.S. Food and Drug Administration (FDA) controversy. And you shouldn’t count on getting access to experimental monoclonal antibodies like the ones that Donald Trump says got him back out on the campaign trail—at least not anytime soon. Plus, there are a host of once-promising therapies that probably don’t work at all, pointing to the frustratingly short menu of options available to Americans in a slew of states experiencing record COVID-19 hospitalizations.
Welcome to Rabbit Hole, where we dive deep on the biggest story. It’s for Beast Inside members only. Join up today.